NewAmsterdam Pharma Company N.V. (NAMS) ROA
- 2026-06-30: ROA -36.84%.
- 2026-03-31: ROA -29.04%.
- 2025-12-31: ROA -26.49%.
- 2025-09-30: ROA -28.11%.
Complete source-backed roa history.
- Available history
- 2022-12-31 to 2026-06-30
- Data captured
Historical ROA
| Date | ROA |
|---|---|
| 2026-06-30 | -36.84% |
| 2026-03-31 | -29.04% |
| 2025-12-31 | -26.49% |
| 2025-09-30 | -28.11% |
| 2025-06-30 | -20.33% |
| 2025-03-31 | -22.89% |
| 2024-12-31 | -27.94% |
| 2024-09-30 | -45.29% |
| 2024-06-30 | -51.36% |
| 2024-03-31 | -46.82% |
| 2023-12-31 | -50.98% |
Annual ROA
| Date | ROA |
|---|---|
| 2025-12-31 | -26.49% |
| 2024-12-31 | -27.94% |
| 2023-12-31 | -50.98% |
| 2022-12-31 | -4.73% |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |
| Harmony Biosciences Holdings, Inc. (HRMY) | United States | $2.399B | 11.67 |